AstraZeneca in the News: EMA Greenlights RSV Vaccine, Leif Johansson Departing
Summary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…